Methylphenidate reduces ADHD symptoms in children with severe ADHD and intellectual disability

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Evidence-Based Mental Health

• Publication date

  2013-08-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1136/eb-2013-101454PMID 23996111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

  2013cited by this paper
• Modifiers of Long-Term School Outcomes for Children with Attention-Deficit/Hyperactivity Disorder: Does Treatment with Stimulant Medication Make a Difference? Results from a Population-Based Study

  2007cited by this paper
• Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder: Results from a Population-Based Study

  2006cited by this paper
• National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.

  2004cited by this paper

• Efficacy and safety of methylphenidate on attention deficit hyperactivity disorder in children with Down syndrome.

  2021cites this paper
• A guide to psychopharmacological treatment of patients with intellectual disability in psychiatry

  2017cites this paper
• Intellectual Disabilities and Global Developmental Delay

  2017cites this paper